ARCA Biopharma Inc

Type: Company
Name: ARCA Biopharma Inc
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Potential Blockbuster Drug Could Move ARCA's Share Price Higher

0 comments Jul 29, 2014 1:39 PM| about stocks: ABIO , MDT , MRK , BMY(click to enlarge) ARCA Biopharma (NASDAQ: ABIO ), a company focused on producing genetically-targeted remedies for cardiovascular diseases, disclosed that the first patient has already ... [Published Seeking Alpha - 22 hours ago]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

ARCA Biopharma: An Undervalued Biotech With A Bright Future

By JMY Investments :I first wrote about Arca Biopharma ( ABIO ) in August, 2013, in the following article, Arca Biopharma Prepares For A Second Life . I considered the stock a value play and still do. Close to a year later, I thought it was a good time ... [Published BioPortfolio - Jul 03 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

5 Stocks Under $10 Set to Soar

 Delafield, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline ... [Published The Street Latest - May 29 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

ARCA biopharma to Present at the Growth Capital Expo 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ... [Published Business Wire Health News - Apr 22 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 3 reports

ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

ARCA biopharma Files Shelf Registration Statement

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with ... [Published Business Wire Health News - Apr 04 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

ARCA biopharma CEO Michael R. Bristow to Be Interviewed Live Today on Clear Channel Business Talk Radio

Interview Scheduled at 11:05am PDT / 12:05 pm MDT / 2:05pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba ... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Entities: ARCA Biopharma Inc
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Small-Cap Biotech on the Verge of a Breakout: ABIO

DELAFIELD, Wis. (Stockpickr) -- Small-cap biotech stocks are all the rage on Wall Street right now. >>5 Stocks With Big Insider BuyingJust take a look at shares of Oxigene , which are ripping higher today by close to 100% after the company reported ... [Published The Street Latest - Mar 12 2014]
First reported Feb 12 2014 - Updated Feb 12 2014 - 2 reports

ARCA adds to board of directors

ARCA biopharma has appointed Dan Mitchell to its board of directors. Mitchell is a manager of Sequel Venture Partners , which he founded. Based in Colorado, ARCA is a biopharmaceutical company focused on cardiovascular diseases. PRESS RELEASE WESTMINSTER, ... [Published PE Hub Blog - Feb 12 2014]
First reported Feb 05 2014 - Updated Feb 05 2014 - 1 reports

5 Stocks Insiders Love Right Now

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>5 Ways to Invest Like a Pension FundThey might need the cash for a big personal purchase such as a new house or yacht, or they might need ... [Published The Street Latest - Feb 05 2014]
First reported Feb 04 2014 - Updated Feb 04 2014 - 1 reports

ARCA biopharma Announces Pricing of $9 Million Public Offering of Common Stock and Warrants

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has priced its previously announced public offering of ... [Published Business Wire Health News - Feb 04 2014]
First reported Feb 03 2014 - Updated Feb 03 2014 - 1 reports

ARCA biopharma Announces Proposed Public Offering of Common Stock and Warrants

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it intends to offer and sell common stock and warrants in ... [Published Business Wire Health News - Feb 03 2014]

Quotes

..." Giroux said he has been commanded to "take the investigation any direction it goes involving criminality in the mayor or the mayor's office." ( http://link.reuters.com/nyx56v )

More Content

All (20) | News (8) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Potential Blockbuster Drug Could Move ARCA's Sh... [Published Seeking Alpha - 22 hours ago]
ARCA Biopharma: An Undervalued Biotech With A B... [Published BioPortfolio - Jul 03 2014]
5 Stocks Under $10 Set to Soar [Published The Street Latest - May 29 2014]
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Health News - Apr 17 2014]
ARCA biopharma Announces Screening of First Pat... [Published Business Wire News with Multimedia - Apr 17 2014]
ARCA biopharma Files Shelf Registration Statement [Published Business Wire Health News - Apr 04 2014]
ARCA biopharma CEO Michael R. Bristow to Be Int... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Small-Cap Biotech on the Verge of a Breakout: ABIO [Published The Street Latest - Mar 12 2014]
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
4 Biotech Stocks Under $10 Moving Higher [Published The Street Latest - Feb 26 2014]
ARCA adds to board of directors [Published PE Hub Blog - Feb 12 2014]
Dan Mitchell Joins ARCA biopharma Board of Dire... [Published Business Wire Health News - Feb 12 2014]
5 Stocks Insiders Love Right Now [Published The Street Latest - Feb 05 2014]
Top Insider Trades: PSX YRCW CRTX IDIX [Published The Street Latest - Feb 05 2014]
ARCA biopharma Announces Pricing of $9 Million ... [Published Business Wire Health News - Feb 04 2014]
Frontrunning: February 4 [Published Zero Hedge - Feb 04 2014]
ARCA biopharma Announces Proposed Public Offeri... [Published Business Wire Health News - Feb 03 2014]
ARCA, DCRI enter clinical trial agreement for G... [Published Pharmaceutical Business Review - Nov 08 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ARCA biopharma to Present at the Growth Capital... [Published Business Wire Health News - Apr 22 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA to present at Growth Capital Expo 2014 investor conference being held April 29 - May 1, 2014. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Photo/Multimedia News - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire Health News - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Announces Screening of First Pat... [Published Business Wire News with Multimedia - Apr 17 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA announces the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 clinical trial that will evaluate Gencaro as a potential genetically targeted treatment for A-fib. ...
ARCA biopharma Files Shelf Registration Statement [Published Business Wire Health News - Apr 04 2014]
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration statement with ...
1 2 3

Press Releases

sort by: Date | Relevance
Top Gainers Technical Data: Ocean Power Technol... [Published Financial Services - Mar 12 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.